CoraLite® Plus 488-conjugated TCOF1 Recombinant antibody

TCOF1 Uni-rAbTM Recombinant Antibody for IF/ICC

Cat No. CL488-84914-5
Clone No.242201F12

Host / Isotype

Rabbit / IgG

Reactivity

human

Applications

IF/ICC

242201F12, MFD1, treacle

Formulation:  PBS and Azide
PBS and Azide
Conjugate:  CoraLite® Plus 488
Size/Concentration: 

-/ -

Freight/Packing: -

Quantity

Please visit your regions distributor:


Tested Applications

Positive IF/ICC detected inMCF-7 cells

Recommended dilution

ApplicationDilution
Immunofluorescence (IF)/ICCIF/ICC : 1:50-1:500
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

CL488-84914-5 targets TCOF1 in IF/ICC applications and shows reactivity with human samples.

Tested Reactivity human
Host / Isotype Rabbit / IgG
Class Recombinant
Type Antibody
Immunogen TCOF1 fusion protein Ag1447 Predict reactive species
Full Name Treacher Collins-Franceschetti syndrome 1
Calculated Molecular Weight 97 kDa, 144 kDa, 152 kDa
GenBank Accession NumberBC014559
Gene Symbol TCOF1
Gene ID (NCBI) 6949
Conjugate CoraLite® Plus 488 Fluorescent Dye
Excitation/Emission Maxima Wavelengths493 nm / 522 nm
Form Liquid
Purification MethodProtein A purification
UNIPROT IDQ13428
Storage Buffer PBS with 50% glycerol, 0.05% Proclin300, 0.5% BSA, pH 7.3.
Storage ConditionsStore at -20°C. Avoid exposure to light. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.

Background Information

TCOF1 also known as treacle, is a nucleolar protein with a LIS1 homology domain. TCOF1 is involved in ribosomal DNA gene transcription by interacting with upstream binding factor (UBF). Mutations in TCOF1 have been associated with Treacher Collins syndrome, a disorder which includes abnormal craniofacial development(PMID: 31218872)

Protocols

Product Specific Protocols
IF protocol for CL Plus 488 TCOF1 antibody CL488-84914-5Download protocol
Standard Protocols
Click here to view our Standard Protocols
Loading...